TRAVERE THERAPEUTICS, INC.: operating_income
| Value | {"amount": -24773448, "concept": "us-gaap:OperatingIncomeLoss", "currency": "USD"} |
|---|---|
| Period | 2013-01-01 – 2013-12-31 |
| Status | superseded |
| Entity | TRAVERE THERAPEUTICS, INC. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T14:10:32.965170+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/c8a04fc7-76ec-45c5-b6a5-07ef9f999ba4
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001571049-15-001817Retrieved: 2026-08-19T14:10:32.965170+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001438533/operating-income/2013-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/c8a04fc7-76ec-45c5-b6a5-07ef9f999ba4
History
- supersedes {"amount": -23972073, "concept": "us-gaap:OperatingIncomeLoss", "currency": "USD"} (evidence 0001193805-14-000650)